Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 15;56(4):1875-91.
doi: 10.1016/j.neuroimage.2011.03.077. Epub 2011 Apr 8.

Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects

Affiliations

Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects

Derrek P Hibar et al. Neuroimage. .

Abstract

Imaging traits provide a powerful and biologically relevant substrate to examine the influence of genetics on the brain. Interest in genome-wide, brain-wide search for influential genetic variants is growing, but has mainly focused on univariate, SNP-based association tests. Moving to gene-based multivariate statistics, we can test the combined effect of multiple genetic variants in a single test statistic. Multivariate models can reduce the number of statistical tests in gene-wide or genome-wide scans and may discover gene effects undetectable with SNP-based methods. Here we present a gene-based method for associating the joint effect of single nucleotide polymorphisms (SNPs) in 18,044 genes across 31,662 voxels of the whole brain in 731 elderly subjects (mean age: 75.56±6.82SD years; 430 males) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Structural MRI scans were analyzed using tensor-based morphometry (TBM) to compute 3D maps of regional brain volume differences compared to an average template image based on healthy elderly subjects. Using the voxel-level volume difference values as the phenotype, we selected the most significantly associated gene (out of 18,044) at each voxel across the brain. No genes identified were significant after correction for multiple comparisons, but several known candidates were re-identified, as were other genes highly relevant to brain function. GAB2, which has been previously associated with late-onset AD, was identified as the top gene in this study, suggesting the validity of the approach. This multivariate, gene-based voxelwise association study offers a novel framework to detect genetic influences on the brain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A histogram shows the minimum null P-values obtained from permutation tests. Data from 3 different voxels are shown on the same graph (blue, red, and black lines); they are obtained from 3 randomly chosen, uncorrelated voxels in the brain (5000 permutations each). The distributions are nearly identical, and agree with each other, as well as accurately reflecting the effective number of independent tests (Meff).
Figure 2
Figure 2
Genetic association plots for univariate linear regression versus multi-locus PCReg. The -log10(P-value) of each SNP in GRIN2B (a) and BEST3 (b) is plotted against its position in the gene. Each of the points is color coded by level of LD (compared to the top SNP, the purple diamond dot) as measured by r2. The −log10(P-value) of the gene-based PCReg test for each gene is overlaid on the plot for comparison (dotted black line). Plots were generated using the LocusZoom software (http://csg.sph.umich.edu/locuszoom/).
Figure 3
Figure 3
A color-coded significance map of the top gene at each voxel. Sections are shown at 8mm intervals throughout the brain. The top of each panel represents the anterior of the brain and bottom the posterior of the brain. The images are in radiological convention (the left side of the image is the patient’s right hemisphere). Color coding is based on the −log10(P-value); warmer colors represent more significant associations.
Figure 4
Figure 4
Cluster sizes in vGeneWAS (red line) are compared with an average of simulated null maps (black line). We took the log10 of the number of voxels in a cluster (not in mm3) across the brain in both maps for scaling purposes and for ease of comparison. The log10 cluster sizes are then plotted using a density function such that the total area under each line is equal to 1. The average simulated null map contains a larger proportion of small cluster sizes than vGeneWAS (higher peaks in the black line at values close to the origin on the x-axis). The vGeneWAS map contains a larger proportion of large cluster sizes than the average simulated null map (the red line is higher at larger values and is more extended). A single slice view of the vGeneWAS and average simulated null cluster maps are pictured for comparison (inset). Every unique cluster is assigned its own color. There are more unique clusters than distinct colors making visual inspection difficult, but in general the clusters in the vGeneWAS maps are larger.
Figure 5
Figure 5
Regions in the brain associated with the top 5 genes from our vGeneWAS analysis (where the uncorrected P-value at a given voxel is overlaid on the minimum deformation template). The slices chosen best represent the regions where each gene was the most significantly associated gene in the brain. Images read from inferior to superior (left to right of the page) following radiological convention and with the top and bottom of each panel representing the anterior and posterior of the brain, respectively.
Figure 6
Figure 6
(a) The normalized histogram of observed P-values. The dashed line represents the cumulative distribution function (CDF) of Beta(1, 18044) where Meff is based on the number of genes tested. The solid line represents the CDF of Beta(1, 15636) where Meff is an estimate of the number of independent tests from permutation testing. (b) The Q-Q plot shows the observed P-values versus those expected from a Beta(1, 15636) distribution (black dots). The solid gray line represents a purely null distribution of P-values. (c) The histogram of corrected P-values (Pc) approximately follows a uniform distribution. (d) The Q-Q plot of the observed Pc versus those expected from a null distribution.
Figure 7
Figure 7
Map of P-values for GAB2 at every voxel in the brain after correction for multiple comparisons across voxels (but not corrected for search across the genome, as we are only testing one gene) using the original FDR method. P-values significant after FDR correction (at q = 3.4×10−4) are color-coded. Warmer colors are more significant. GAB2 has a more distributed effect on the brain than is evident in the vGeneWAS results.
Figure 8
Figure 8
Genetic association plot, for different SNPs in the GAB2 gene, at the top voxel from our analysis. The -log10(P-value) of each SNP in GAB2 is plotted against its position in the gene. Each of the points is color coded by level of LD (compared to the top SNP, the purple diamond dot) as measured by r2. The −log10(P-value) of the gene-based PCReg test for GAB2 at this voxel is overlaid on the plot for comparison (dotted black line). In this case, the gene-based test shows a greater effect size than univariate tests on any of the component SNPs treated independently. This shows that the gene-based test can be more powerful than performing separate tests on component SNPs.
Figure 9
Figure 9
vGeneWAS may control the false discovery rate better than vGWAS. The cumulative distribution function (CDF) of Pc-values from vGeneWAS (solid green line) is compared to the CDF of Pc-values from vGWAS (Stein et al. 2010a; solid black line). Three lines represent different correction thresholds of q = 0.05 (red dashed line), q = 0.30 (black dashed line), and q = 0.50 (blue dotted line).

Similar articles

Cited by

References

    1. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P, Gibbs RA, Belmont JW, Boudreau A, Leal SM, Hardenbol P, Pasternak S, Wheeler DA, Willis TD, Yu FL, Yang HM, Zeng CQ, Gao Y, Hu HR, Hu WT, Li CH, Lin W, Liu SQ, Pan H, Tang XL, Wang J, Wang W, Yu J, Zhang B, Zhang QR, Zhao HB, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L, Shen Y, Yao ZJ, Huang W, Chu X, He YG, Jin L, Liu YF, Shen YY, Sun WW, Wang HF, Wang Y, Wang Y, Wang Y, Xiong XY, Xu L, Waye MMY, Tsui SKW, Xue H, Wong JTF, Galver ILM, Fan JB, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon F, Ferretti V, Leboeuf M, Olivier JF, Phillips MS, Roumy S, Sallee C, Verner A, Hudson TJ, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Kwok PY, Cai DM, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui LC, Mak W, Sham PC, Song YQ, Tam PKH, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A, Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird CP, Delgado M, Dermitzakis ET, Gwilliam R, Hunt S, Morrison J, Powell D, Stranger BE, Whittaker P, Bentley DR, Daly MJ, de Bakker PIW, Barrett J, Fry B, Maller J, McCarroll S, Patterson N, Pe’er I, Purcell S, Richter DJ, Sabeti P, Saxena R, Schaffner SF, Varilly P, Stein LD, Krishnan L, Smith AV, Thorisson GA, Chen PE, Cutler DJ, Kashuk CS, Lin S, Abecasis GR, Guan WH, Munro HM, Qin ZHS, Thomas DJ, McVean G, Bottolo L, Eyheramendy S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M, Cardon LR, Clarke G, Evans DM, Morris AP, Weir BS, Tsunoda T, Mullikin JC, Sherry ST, Feolo M, Zhang HC, Zeng CQ, Zhao H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Ajayi I, Aniagwu T, Marshall PA, Nkwodimmah C, Royal CDM, Leppert MF, Dixon M, Peiffer A, Qiu RZ, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers BM, Foster MW, Clayton EW, Muzny D, Nazareth L, Sodergren E, Weinstock GM, Wheeler DA, Yakub I, Gabriel SB, Richter DJ, Ziaugra L, Birren BW, Wilson RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM, Griffiths M, Jones MC, McLay K, Plumb RW, Ross MT, Sims SK, Willey DL, Chen Z, Han H, Kang L, Godbout M, Wallenburg JC, Archeveque PL, Bellemare G, Saeki K, Wang HG, An DC, Fu HB, Li Q, Wang Z, Wang RW, Holden AL, Brooks LD, McEwen JE, Bird CR, Guyer MS, Nailer PJ, Wang VO, Peterson JL, Shi M, Spiegel J, Sung LM, Witonsky J, Zacharia LF, Kennedy K, Jamieson R, Stewart J, Consortium IH. A haplotype map of the human genome. Nature. 2005;437:1299–1320. - PMC - PubMed
    1. Bagnoli S, Nacmias B, Tedde A, Guarnieri BM, Cellini E, Petruzzi C, Bartoli A, Ortenzi L, Sorbi S. Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer’s disease in Italy. Ann Neurol. 2004;55:447–448. - PubMed
    1. Bansal V, Libiger O, Torkamani A, Schork NJ. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet. 2010;11:773–785. - PMC - PubMed
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological. 1995;57:289–300.
    1. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Annals of Statistics. 2001;29:1165–1188.

Publication types

Substances